Alvotech And Cipla Strike Biosimilars Alliance In South Africa
Deal Covers Five Undisclosed Biosimilars
The partnership provides for five biosimilars – two for oncology and three for treating autoimmune diseases – in certain emerging markets, including South Africa. • Source: Shutterstock
